Then, by using the mouse Hoxa9 transduction AML model, we demonstrated that Phf6 loss led to increased colony replating, increased disease burden in vivo, progressively worsened survival on serial transplantation, and increased LIC frequency. Here, HOXA9 is linked to acute myeloid leukemia.